Early induction of interferon-responsive mRNAs in Creutzfeldt-Jakob disease

Christopher A Baker1, Zhi Yun Lu, Laura Manuelidis

  • 1Section of Neuropathology, Yale School of Medicine, New Haven, Connecticut, USA.

Journal of Neurovirology
|February 26, 2004
PubMed

Insights

The prion agent in Creutzfeldt-Jakob disease (CJD) triggers early immune responses in microglia, similar to viral infections, potentially aiding in preclinical diagnosis.

Area of Science:

  • Neuroimmunology
  • Prion Diseases
  • Infectious Agents

Background:

  • Creutzfeldt-Jakob disease (CJD) typically shows no host immune response.
  • Persistent viruses can evade immune recognition while activating inflammatory pathways.
  • Previous studies noted microglial responses in late-stage CJD, but their cause was unclear.

Purpose of the Study:

  • To investigate early microglial responses in CJD.
  • To determine if CJD agents activate distinct signaling pathways.
  • To explore the potential for early CJD diagnosis.

Main Methods:

  • Analysis of microglial transcriptional changes in CJD brains.
  • Comparison of CJD-induced pathways with those of amyloidogenic proteins.
  • Assessment of interferon response in CJD microglia.

Main Results:

  • Microglial transcriptional changes and interferon-sensitive gene upregulation detected in CJD brains 30 days post-inoculation, preceding clinical signs.
  • CJD agent activated distinct signaling pathways in microglia compared to abnormal prion protein.
  • CJD microglia showed potentiated interferon response to double-stranded RNA, despite lacking increased interferon synthesis.

Conclusions:

  • The CJD agent is recognized as a foreign, virus-like entity by the host.
  • Early reactive gene expression in microglia may serve as a preclinical diagnostic marker for CJD.